PMID- 18495100 OWN - NLM STAT- MEDLINE DCOM- 20080821 LR - 20220331 IS - 1090-2163 (Electronic) IS - 0008-8749 (Linking) VI - 251 IP - 2 DP - 2008 Feb TI - Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. PG - 116-23 LID - 10.1016/j.cellimm.2008.04.003 [doi] AB - Mesenchymal stromal cells (MSCs) are promising candidates for developing cell therapies for intractable diseases. To assess the feasibility of transplantation with human umbilical cord blood (hUCB)-derived MSCs, we analyzed the ability of these cells to function as alloantigen-presenting cells (APC) in vitro. hUCB-MSCs were strongly positive for MSC-related antigens and stained positively for human leukocyte antigen (HLA)-AB and negatively for HLA-DR. When treated with interferon (IFN)-gamma, the expression of HLA-AB and HLA-DR, but not the co-stimulatory molecules CD80 and CD86, was increased. hUCB-MSCs did not provoke allogeneic PBMC (peripheral blood mononuclear cell) proliferation, even when their HLA-molecule expression was up-regulated by IFN-gamma pretreatment. When added to a mixed lymphocyte reaction (MLR), hUCB-MSCs actively suppressed the allogeneic proliferation of the responder lymphocytes. This suppressive effect was mediated by soluble factors. We conclude that hUCB-MSCs can suppress the allogeneic response of lymphocytes and may thus be useful in allogeneic cell therapies. FAU - Oh, Wonil AU - Oh W AD - Medipost Biomedical Research Institute, Medipost Co Ltd, Asan Institute of Life Science, Seoul, Republic of Korea. FAU - Kim, Dal-Soo AU - Kim DS FAU - Yang, Yoon Sun AU - Yang YS FAU - Lee, Jae Kwon AU - Lee JK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080520 PL - Netherlands TA - Cell Immunol JT - Cellular immunology JID - 1246405 RN - 0 (Cytokines) RN - 0 (Histocompatibility Antigens Class I) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Cell Differentiation/immunology MH - Cytokines/biosynthesis MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Fetal Blood/cytology/*immunology MH - Flow Cytometry MH - Histocompatibility Antigens Class I/biosynthesis MH - Humans MH - Immunophenotyping MH - Infant, Newborn MH - Interferon-gamma/pharmacology MH - Leukocytes, Mononuclear/cytology/drug effects/immunology MH - Lymphocyte Activation MH - Lymphocyte Culture Test, Mixed MH - Mesenchymal Stem Cells/cytology/drug effects/*immunology MH - Mesoderm MH - Pregnancy MH - Stromal Cells/cytology/drug effects/immunology EDAT- 2008/05/23 09:00 MHDA- 2008/08/22 09:00 CRDT- 2008/05/23 09:00 PHST- 2008/01/09 00:00 [received] PHST- 2008/03/29 00:00 [revised] PHST- 2008/04/04 00:00 [accepted] PHST- 2008/05/23 09:00 [pubmed] PHST- 2008/08/22 09:00 [medline] PHST- 2008/05/23 09:00 [entrez] AID - S0008-8749(08)00073-7 [pii] AID - 10.1016/j.cellimm.2008.04.003 [doi] PST - ppublish SO - Cell Immunol. 2008 Feb;251(2):116-23. doi: 10.1016/j.cellimm.2008.04.003. Epub 2008 May 20.